Advertisement
Logo
Search for

Articles in Press

Return to articles in press list

Tonsillectomy for the treatment of tonsillitis-induced immunoglobulin A nephropathy☆☆

Benjamin D. Liess, MDaCorresponding Author Informationemail address, Chelsea Mytyk, BSb, Karen H. Calhoun, MDa, Adam T. Whaley-Connell, DOc

Received 17 May 2009 published online 12 October 2009.
Corrected Proof

Abstract 

Tubular occlusion from red blood cell casts secondary to immunoglobulin A nephropathy (IgAN) is a rare, serious complication of tonsillitis that can cause acute renal failure, also referred to as acute kidney injury. IgAN is the most common primary glomerulonephritis with up to 20% of cases resulting in renal failure worldwide. Tonsillectomy is an effective treatment option for patients suffering from IgAN secondary to recurrent acute tonsillitis. Tonsillectomy alone or in combination with additional medical modalities improves renal function and can have a positive effect on long-term renal survival.

a Department of Otolaryngology-Head and Neck Surgery, University of Missouri School of Medicine, Columbia, MO, USA

b University of Missouri-Columbia School of Medicine, Columbia, MO, USA

c Division of Nephrology, Department of Internal Medicine, University of Missouri School of Medicine, Columbia, MO, USA

Corresponding Author InformationCorresponding author. Department of Otolaryngology-Head and Neck Surgery, University of Missouri School of Medicine, One Hospital Drive, Columbia, MO 65212, USA. Tel.: +1 573 882 8174; fax: +1 573 884 4205.

 Submission of this article is understood to imply that the article is original and is not being considered for publication elsewhere. In consideration of American Journal of Otolaryngology reviewing and editing my submission, “Tonsillectomy for the treatment of tonsillitis-induced IgA nephropathy” the author(s) undersigned transfers, assigns, and otherwise conveys all copyright ownership of the article to the publisher. Each of the authors has contributed to, read, and approved this manuscript. This manuscript has not been previously published. The UMHC IRB has approved this study.

☆☆ Financial Disclosure: Dr Whaley-Connell reports research funding from the VA VISN 15 and the Missouri Kidney Program.

PII: S0196-0709(09)00165-3

doi:10.1016/j.amjoto.2009.08.007

Advertisement